ENVB
Price
$0.76
Change
-$0.03 (-3.80%)
Updated
Oct 17 closing price
Capitalization
4.72M
PRQR
Price
$2.78
Change
-$0.02 (-0.71%)
Updated
Oct 17 closing price
Capitalization
292.86M
18 days until earnings call
Interact to see
Advertisement

ENVB vs PRQR

Header iconENVB vs PRQR Comparison
Open Charts ENVB vs PRQRBanner chart's image
Enveric Biosciences
Price$0.76
Change-$0.03 (-3.80%)
Volume$282.03K
Capitalization4.72M
ProQR Therapeutics
Price$2.78
Change-$0.02 (-0.71%)
Volume$1.12M
Capitalization292.86M
ENVB vs PRQR Comparison Chart in %
ENVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENVB vs. PRQR commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENVB is a Hold and PRQR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (ENVB: $0.76 vs. PRQR: $2.78)
Brand notoriety: ENVB and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENVB: 45% vs. PRQR: 240%
Market capitalization -- ENVB: $4.72M vs. PRQR: $292.86M
ENVB [@Biotechnology] is valued at $4.72M. PRQR’s [@Biotechnology] market capitalization is $292.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENVB’s FA Score shows that 1 FA rating(s) are green whilePRQR’s FA Score has 1 green FA rating(s).

  • ENVB’s FA Score: 1 green, 4 red.
  • PRQR’s FA Score: 1 green, 4 red.
According to our system of comparison, PRQR is a better buy in the long-term than ENVB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENVB’s TA Score shows that 4 TA indicator(s) are bullish while PRQR’s TA Score has 5 bullish TA indicator(s).

  • ENVB’s TA Score: 4 bullish, 4 bearish.
  • PRQR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ENVB and PRQR are a good buy in the short-term.

Price Growth

ENVB (@Biotechnology) experienced а +21.46% price change this week, while PRQR (@Biotechnology) price change was +15.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

PRQR is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRQR($293M) has a higher market cap than ENVB($4.72M). PRQR YTD gains are higher at: 4.906 vs. ENVB (-85.880). ENVB has higher annual earnings (EBITDA): -9.68M vs. PRQR (-35.56M). PRQR has more cash in the bank: 120M vs. ENVB (2.85M). ENVB has less debt than PRQR: ENVB (0) vs PRQR (16.9M). PRQR has higher revenues than ENVB: PRQR (16.5M) vs ENVB (0).
ENVBPRQRENVB / PRQR
Capitalization4.72M293M2%
EBITDA-9.68M-35.56M27%
Gain YTD-85.8804.906-1,751%
P/E RatioN/AN/A-
Revenue016.5M-
Total Cash2.85M120M2%
Total Debt016.9M-
FUNDAMENTALS RATINGS
ENVB vs PRQR: Fundamental Ratings
ENVB
PRQR
OUTLOOK RATING
1..100
223
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9438
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
849

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENVB's Valuation (20) in the Electronics Or Appliances industry is in the same range as PRQR (33) in the Biotechnology industry. This means that ENVB’s stock grew similarly to PRQR’s over the last 12 months.

ENVB's Profit vs Risk Rating (100) in the Electronics Or Appliances industry is in the same range as PRQR (100) in the Biotechnology industry. This means that ENVB’s stock grew similarly to PRQR’s over the last 12 months.

PRQR's SMR Rating (98) in the Biotechnology industry is in the same range as ENVB (100) in the Electronics Or Appliances industry. This means that PRQR’s stock grew similarly to ENVB’s over the last 12 months.

PRQR's Price Growth Rating (38) in the Biotechnology industry is somewhat better than the same rating for ENVB (94) in the Electronics Or Appliances industry. This means that PRQR’s stock grew somewhat faster than ENVB’s over the last 12 months.

PRQR's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ENVB (100) in the Electronics Or Appliances industry. This means that PRQR’s stock grew similarly to ENVB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENVBPRQR
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ENVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOLV72.160.72
+1.01%
Solventum Corp
EVTL4.82-0.18
-3.60%
Vertical Aerospace Ltd
SCNI1.40-0.06
-4.11%
Scinai Immunotherapeutics Ltd.
MESO17.07-1.02
-5.64%
Mesoblast Limited
RYM42.52-3.29
-7.18%
RYTHM Inc

ENVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENVB has been loosely correlated with PRQR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ENVB jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENVB
1D Price
Change %
ENVB100%
-3.68%
PRQR - ENVB
43%
Loosely correlated
-0.71%
ALNY - ENVB
36%
Loosely correlated
+0.12%
ORMP - ENVB
33%
Poorly correlated
-1.76%
SLNCF - ENVB
28%
Poorly correlated
N/A
ARQT - ENVB
28%
Poorly correlated
-0.14%
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been closely correlated with WVE. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if PRQR jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
-0.71%
WVE - PRQR
67%
Closely correlated
-0.76%
KRRO - PRQR
55%
Loosely correlated
-13.27%
ETHZ - PRQR
44%
Loosely correlated
+0.60%
ENVB - PRQR
43%
Loosely correlated
-3.68%
OCUL - PRQR
35%
Loosely correlated
-2.95%
More